(Q43036942)

12 November 2017

title

Real-time RT-PCR for quantitation of hepatitis C virus RNA. (English)

1 reference

12 November 2017

1 reference

1 reference

Ji Hong Yang

1

1 reference

12 November 2017

Jian Ping Lai

2

1 reference

12 November 2017

Steven D Douglas

3

1 reference

12 November 2017

David Metzger

4

1 reference

12 November 2017

Xian Hua Zhu

5

1 reference

12 November 2017

Wen Zhe Ho

6

1 reference

12 November 2017

publication date

1 April 2002

1 reference

Journal of Virological Methods

12 November 2017

published in

1 reference

12 November 2017

volume

102

1 reference

12 November 2017

issue

1-2

1 reference

12 November 2017

page(s)

119-128

1 reference

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

The scientific challenge of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Quantitative or semi-quantitative PCR: reality versus myth

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Quantitative PCR: theoretical considerations with practical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Taking DNA probes into a protein world

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Multicolor molecular beacons for allele discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Molecular beacons: probes that fluoresce upon hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Multiplex detection of four pathogenic retroviruses using molecular beacons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900007-1

7 January 2021

10.1016/S0166-0934(02)00007-1

Identifiers

DOI

1 reference

12 November 2017

1 reference